Hemodialysis‐Associated Hepatitis B: Revised Recommendations for Serologic Screening

Hepatitis B virus (HBV) infection has historically been a major health problem among hemodialysis patients and staff. Routine serologic screening, infection control practices, and the use of hepatitis B vaccine have had a major impact on the prevention of HBV transmission. In this article we review historical trends, review preventive measures, and offer revised recommendations for screening in hemodialysis centers.

[1]  M. Alter,et al.  National Surveillance of Dialysis‐Associated Diseases in the United States, 1988 , 1990, ASAIO transactions.

[2]  B. McMahon,et al.  Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. , 1989, JAMA.

[3]  M. Alter,et al.  Hemodialysis-associated hepatitis B: report of an outbreak , 1989 .

[4]  J. Davis,et al.  Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin. , 1988, American journal of epidemiology.

[5]  J. Hamilton,et al.  Hepatitis B vaccines in patients with chronic renal failure before dialysis. , 1988, The Journal of infectious diseases.

[6]  Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. , 1988, New York state journal of medicine.

[7]  I. Hughes.  Care of the Child with Diabetes , 1987 .

[8]  A. Mayor,et al.  Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients. , 1987, Postgraduate medical journal.

[9]  S. Hadler,et al.  Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. , 1986, The New England journal of medicine.

[10]  F. Deinhardt,et al.  Immunogenicity of recombinant hepatitis B vaccine in dialysis patients. , 1986, Journal of hepatology.

[11]  W. Szmuness,et al.  Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. , 1984, The New England journal of medicine.

[12]  L. Saravolatz,et al.  The risk of hepatitis B among select employee groups in an urban hospital. , 1983, JAMA.

[13]  M. Alter,et al.  Cost benefit of vaccination for hepatitis B in hemodialysis centers. , 1983, The Journal of infectious diseases.

[14]  M. Alter,et al.  Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. , 1983, Annals of internal medicine.

[15]  M. Alter,et al.  National surveillance of dialysis-associated hepatitis and other diseases. 1976 and 1980 , 1983 .

[16]  W. Szmuness,et al.  Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. , 1982, The New England journal of medicine.

[17]  M. Lavenhar,et al.  Control of Hepatitis B Infection: The Role of Surveillance and an Isolation Hemodialysis Center , 1981 .

[18]  M. Lavenhar,et al.  Control of hepatitis B infection. The role of surveillance and an isolation hemodialysis center. , 1981, JAMA.

[19]  W. Szmuness,et al.  HEPATITIS B VACCINE: IMMUNE RESPONSES IN HAEMODIALYSIS PATIENTS , 1980, The Lancet.

[20]  D. Snydman,et al.  Hemodialysis-Associated Hepatitis in the United States, 1974 , 1977 .

[21]  J. Guàrdia,et al.  [Hepatitis B in a hemodialysis unit]. , 1976, Revista clinica espanola.

[22]  D. Snydman,et al.  Transmission of hepatitis B associated with hemodialysis: role of malfunction (blood leaks) in dialysis machines. , 1976, The Journal of infectious diseases.

[23]  C. Pattison.  Hepatitis as a hemodialysis hazard. , 1974, American heart journal.

[24]  M. K. Mann,et al.  Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. , 1974 .